Journal
NATURE REVIEWS CANCER
Volume 9, Issue 12, Pages 849-861Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc2733
Keywords
-
Categories
Funding
- US National Institutes of Health [CA95060, GM085585, CA122952]
- Leukemia & Lymphoma Society [6225-08]
Ask authors/readers for more resources
MYC is deregulated in most tumour types, but an effective means to selectively target its aberrant expression is not yet available. Supercoiling that is induced by transcription has been demonstrated to have dynamic effects on DNA in the MYC promoter element: it converts duplex DNA to non-duplex DNA structures, even at considerable distances from the transcriptional start site. These non-duplex DNA structures, which control both turning on and off of transcription and the rate of transcription firing, are amenable to small-molecule targeting. This dynamic system provides a unique opportunity for the treatment of tumours in which MYC is an important oncogene.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available